CUP: J58I20000020009
(0350000068) Approaching COVID with Boulardii
SUMMARY OF THE PROJECT
(0350000068) Approaching COVID with Boulardii
Implementation indicator
Investimenti privati combinati al sostegno pubblico in progetti di R&S o innovazione
- Target
- 54,183 euro
- Achieved
- 54,183 euro
Download project
Funding monitored
€ 126,427.00
of which cohesion funds
€ 126,427.00
| Given name | Amount |
|---|---|
| European Union | 63213.50 |
| Revolving Fund | 44249.45 |
| Region | 18964.05 |
- Other resources - Private:
- € 54,183
Payments monitored
€ 126,427.00
of which cohesion funds
€ 126,427.00
| Year | Amount | Cumulative amount | Percentage on public financing |
|---|---|---|---|
| 2021 | 126427.00 | 126427.00 | 100 |
State of progress
Completed
Expected start: 12/05/2020
Effective start: 12/05/2020
Expected end: 29/07/2021
Effective end: 10/11/2020
Entities
- Planning body
- REGIONE PIEMONTE
- Implementing body
- REGIONE PIEMONTE
- Beneficiary
- ACEL PHARMA SRL
- Executor
- ACEL PHARMA SRL
Programming area
- Programme
- ROP ERDF PIEDMONT
- European Regional Development Fund (ERDF)
- 2014-2020 EU Structural Funds
- Cohesion funds
- € 126,427.00
- Payments on cohesion funds
- € 126,427.00
- Axis
- RICERCA, SVILUPPO TECNOLOGICO E INNOVAZIONE
- Specific objective
- Potenziamento della capacità di sviluppare l'eccellenza nella R&I